
Insiders Updates
Recent Insider Activity Suggests Potential Gains for MoonLake Immunotherapeutics (MLTX)
In a filing, MoonLake Immunotherapeutics revealed its Former 10% Owner Chen Bihua unloaded Company’s shares for reported $46.83 million on